JANE STREET GROUP, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$8,649,000
+944.6%
492,661
+476.2%
0.00%
Q2 2021$828,000
-39.9%
85,498
-33.5%
0.00%
Q1 2021$1,377,000
-61.5%
128,543
-47.1%
0.00%
-100.0%
Q4 2020$3,572,000
-26.0%
242,819
-28.6%
0.00%
-33.3%
Q3 2020$4,828,000
+1279.4%
340,187
+685.7%
0.00%
Q2 2020$350,000
+104.7%
43,300
-0.2%
0.00%
Q1 2020$171,000
+489.7%
43,405
+51.8%
0.00%
Q4 2019$29,000
+107.1%
28,588
+27.1%
0.00%
Q1 2019$14,000
-67.4%
22,494
-8.8%
0.00%
Q4 2018$43,000
-60.6%
24,662
+28.2%
0.00%
Q4 2016$109,00019,2300.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders